Bristol-Myers Squibb receives positive CHMP Opinion for nivolumab for the treatment of advanced squamous NSCLC in previously-treated patients
22 May 2015 | By Victoria White
The CHMP has adopted a positive opinion recommending that nivolumab be granted approval for the treatment of NSCLC after prior chemotherapy in adults...